Personalis (PSNL) Revenue & Revenue Breakdown
Personalis Revenue Highlights
0
Latest Revenue (Q)
$22.58M
Personalis Revenue by Period
Personalis Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | - | -100.00% |
| 2023-12-31 | $73.48M | 12.97% |
| 2022-12-31 | $65.05M | -23.92% |
| 2021-12-31 | $85.49M | 8.70% |
| 2020-12-31 | $78.65M | 20.61% |
| 2019-12-31 | $65.21M | 72.62% |
| 2018-12-31 | $37.77M | 302.15% |
| 2017-12-31 | $9.39M | - |
Personalis generated - in revenue during NA 2024, up -100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Personalis Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-06-30 | $22.58M | 15.65% |
| 2024-03-31 | $19.52M | -0.76% |
| 2023-12-31 | $19.68M | 7.83% |
| 2023-09-30 | $18.25M | 9.27% |
| 2023-06-30 | $16.70M | -11.46% |
| 2023-03-31 | $18.86M | 12.79% |
| 2022-12-31 | $16.72M | 12.55% |
| 2022-09-30 | $14.86M | -18.54% |
| 2022-06-30 | $18.24M | 19.79% |
| 2022-03-31 | $15.23M | -26.38% |
| 2021-12-31 | $20.68M | -7.09% |
| 2021-09-30 | $22.26M | 2.73% |
| 2021-06-30 | $21.67M | 3.78% |
| 2021-03-31 | $20.88M | 3.49% |
| 2020-12-31 | $20.18M | 1.82% |
| 2020-09-30 | $19.82M | 1.65% |
| 2020-06-30 | $19.50M | 1.74% |
| 2020-03-31 | $19.16M | 5.55% |
| 2019-12-31 | $18.15M | 5.84% |
| 2019-09-30 | $17.15M | 8.39% |
| 2019-06-30 | $15.82M | 12.43% |
| 2019-03-31 | $14.07M | 6.98% |
| 2018-12-31 | $13.16M | 12.90% |
| 2018-09-30 | $11.65M | 32.45% |
| 2018-06-30 | $8.80M | 111.31% |
| 2018-03-31 | $4.16M | - |
Personalis generated $22.58M in revenue during Q2 2024, up 15.65% compared to the previous quarter, and up 119.72% compared to the same period a year ago.
Personalis Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| ILMN | Illumina | $4.37B | $1.08B |
| CRL | Charles River Laboratories | $4.05B | $1.03B |
| NTRA | Natera | $1.70B | $439.76M |
| MYGN | Myriad Genetics | $753.20M | $191.90M |
| GH | Guardant Health | $739.02M | $177.24M |
| BNR | Burning Rock Biotech | $537.43M | $125.62M |
| CDNA | CareDx | $333.79M | $82.88M |
| CSTL | Castle Biosciences | $332.07M | $85.78M |
| TWST | Twist Bioscience | $312.97M | - |
| STIM | Neuronetics | $74.89M | $16.45M |
| DRIO | DarioHealth | $27.04M | $6.25M |
| SERA | Sera Prognostics | $77.00K | $24.00K |
| PSNL | Personalis | - | $22.58M |